These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21933854)

  • 21. Increased transferrin receptor expression following 11q23 deletion as a mechanism of malignant progression in chronic lymphocytic leukemia.
    Shackelford RE; Bhalodia AR; Cotelingam JD; Veillon DM; Lowery-Nordberg M
    Med Hypotheses; 2006; 66(3):509-12. PubMed ID: 16326028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.
    Mao JH; Wu D; DelRosario R; Castellanos A; Balmain A; Perez-Losada J
    Oncogene; 2008 Nov; 27(51):6596-600. PubMed ID: 18679420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
    Boultwood J
    J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATM gene deletion in patients with adult acute lymphoblastic leukemia.
    Haidar MA; Kantarjian H; Manshouri T; Chang CY; O'Brien S; Freireich E; Keating M; Albitar M
    Cancer; 2000 Mar; 88(5):1057-62. PubMed ID: 10699895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia.
    Stilgenbauer S; Schaffner C; Litterst A; Liebisch P; Gilad S; Bar-Shira A; James MR; Lichter P; Döhner H
    Nat Med; 1997 Oct; 3(10):1155-9. PubMed ID: 9334731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.
    Joshi AD; Dickinson JD; Hegde GV; Sanger WG; Armitage JO; Bierman PJ; Bociek RG; Devetten MP; Vose JM; Joshi SS
    Cancer Genet Cytogenet; 2007 Jan; 172(2):120-6. PubMed ID: 17213020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.
    Rose-Zerilli MJ; Forster J; Parker H; Parker A; Rodríguez AE; Chaplin T; Gardiner A; Steele AJ; Collins A; Young BD; Skowronska A; Catovsky D; Stankovic T; Oscier DG; Strefford JC
    Haematologica; 2014 Apr; 99(4):736-42. PubMed ID: 24584352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
    Broeks A; Urbanus JH; Floore AN; Dahler EC; Klijn JG; Rutgers EJ; Devilee P; Russell NS; van Leeuwen FE; van 't Veer LJ
    Am J Hum Genet; 2000 Feb; 66(2):494-500. PubMed ID: 10677309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATM mutations in sporadic lymphoid tumours.
    Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
    Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases.
    Rodriguez C; Vallès H; Causse A; Johannsdottir V; Eliaou JF; Theillet C
    Genes Chromosomes Cancer; 2002 Feb; 33(2):141-9. PubMed ID: 11793440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell analysis of loss of heterozygosity at the ATM gene locus in Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma: ATM loss of heterozygosity is a rare event.
    Lespinet V; Terraz F; Recher C; Campo E; Hall J; Delsol G; Al Saati T
    Int J Cancer; 2005 May; 114(6):909-16. PubMed ID: 15645496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia.
    Mikeska T; Carney DA; Seymour JF; Dobrovic A
    Leuk Lymphoma; 2012 Jul; 53(7):1420-2. PubMed ID: 22204453
    [No Abstract]   [Full Text] [Related]  

  • 33. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.
    Starostik P; Manshouri T; O'Brien S; Freireich E; Kantarjian H; Haidar M; Lerner S; Keating M; Albitar M
    Cancer Res; 1998 Oct; 58(20):4552-7. PubMed ID: 9788599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New translocations in a case of atypical B-cell chronic lymphocytic leukemia: involvement of ATM, MLL, and TP53 genes.
    Collado R; Hueso J; Cabello AI; Oliver I; Egea M; Orero M; Miguel-Sosa A; Cigudosa JC; Benítez J; Barragán E; Carbonell F
    Cancer Genet Cytogenet; 2006 Sep; 169(2):176-8. PubMed ID: 16938579
    [No Abstract]   [Full Text] [Related]  

  • 35. ATM mutations are rare in familial chronic lymphocytic leukemia.
    Yuille MR; Condie A; Hudson CD; Bradshaw PS; Stone EM; Matutes E; Catovsky D; Houlston RS
    Blood; 2002 Jul; 100(2):603-9. PubMed ID: 12091354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion.
    Lozano-Santos C; García-Vela JA; Pérez-Sanz N; Nova-Gurumeta S; Fernandez-Cuevas B; Gomez-Lozano N; Sánchez-Beato M; Sanchez-Godoy P; Bueno JL; Garcia-Marco JA
    Leuk Lymphoma; 2017 Apr; 58(4):859-865. PubMed ID: 27499002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Missense mutations at ATM gene and cancer risk.
    Vorechovsky I; Luo L; Ortmann E; Steinmann D; Dörk T
    Lancet; 1999 Apr; 353(9160):1276. PubMed ID: 10217116
    [No Abstract]   [Full Text] [Related]  

  • 38. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
    Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia.
    Herholz H; Kern W; Schnittger S; Haferlach T; Dicker F; Haferlach C
    Cancer Genet Cytogenet; 2007 Apr; 174(1):57-60. PubMed ID: 17350468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2).
    Jiang Y; Chen HC; Su X; Thompson PA; Liu X; Do KA; Wierda W; Keating MJ; Plunkett W
    Blood Cancer J; 2016 Sep; 6(9):e465. PubMed ID: 27588518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.